Endurant Capital Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $481K | Sell |
|
|||||
|
2023
Q2 | $768K | Sell |
|
|||||
|
2023
Q1 | $3.01M | Sell |
|
|||||
|
2022
Q4 | $4.27M | Sell |
|
|||||
|
2022
Q3 | $6.46M | Sell |
|
|||||
|
2022
Q2 | $6.04M | Buy |
|
|||||
|
2022
Q1 | $4.25M | Buy |
|
|||||
|
2021
Q4 | $6.92M | Buy |
|
|||||
|
2021
Q3 | $4.25M | Buy |
|
|||||
|
2021
Q2 | $3.88M | Buy |
|
|||||
|
2021
Q1 | $4.13M | Sell |
|
|||||
|
2020
Q4 | $3M | Sell |
|
|||||
|
2020
Q3 | $3.75M | Sell |
|
|||||
|
2020
Q2 | $5.05M | Buy |
|
|||||
|
2020
Q1 | $615K | Buy |
|
|||||
|
2019
Q4 | $61K | Buy |
|